AVTX
AVALO THERAP (AVTX)
NASDAQ
$17.63-$0.20 (-1.15%)
Price as of Jun 23, 2026 7:29 PM EDT
  • $897.8M
    Market Cap
  • 260.20%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
ARMISTICE CAPITAL, LLC
35.10%
4.0M
0 (0.00%)
Dec 31, 2022
FMR LLC
25.50%
2.9M
+2.7M (+92.35%)
Mar 31, 2026
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.
19.15%
2.2M
+2.2M (+100.00%)
Mar 31, 2026
CALIGAN PARTNERS LP
14.48%
1.6M
+753,490 (+46.08%)
Mar 31, 2026
BVF INC/IL
14.46%
1.6M
+277,588 (+17.00%)
Mar 31, 2026
STONEPINE CAPITAL MANAGEMENT, LLC
13.37%
1.5M
+660,095 (+43.71%)
Dec 31, 2021
AVORO CAPITAL ADVISORS LLC
12.48%
1.4M
+1.4M (+100.00%)
Mar 31, 2026

Current Ownership Distribution

  • Institutions245.7M (71.07%)
  • Insiders50.5M (14.59%)
  • Mutual Funds49.6M (14.34%)
  • Other0 (0.00%)

Insider Transactions

  • 14.59% (50.5M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 3
    Number of InsiderSelling (last 12 months)
  • $1.5M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Sullivan Christopher Ryan
Chief Financial Officer
In Kind
Jun 10, 2026
$1,807.80
138
$13.10
40,773
Riley Jennifer
Chief Strategy Officer
In Kind
Jun 10, 2026
$7,702.80
588
$13.10
39,696
VARKI PAUL
Chief Legal Officer
In Kind
Jun 10, 2026
$14,161.10
1,081
$13.10
32,576
Doyle Mittie
Chief Medical Officer
In Kind
Jun 10, 2026
$14,200.40
1,084
$13.10
51,776
Doyle Mittie
Chief Medical Officer
Exempt
Apr 06, 2026
$0.00
3,970
$0.00
210,530
Doyle Mittie
Chief Medical Officer
Exempt
Apr 06, 2026
$50,220.50
3,970
$12.65
7,592
Doyle Mittie
Chief Medical Officer
Sell
Apr 06, 2026
$71,508.43
3,970
$18.01
3,622
Sullivan Christopher Ryan
Chief Financial Officer
Sell
Apr 02, 2026
$105,553.14
6,200
$17.02
19,118
Sullivan Christopher Ryan
Chief Financial Officer
Sell
Apr 02, 2026
$31,269.97
1,780
$17.57
17,338
Doyle Mittie
Chief Medical Officer
Exempt
Apr 01, 2026
$0.00
679
$0.00
148,329
Sullivan Christopher Ryan
Chief Financial Officer
Sell
Apr 01, 2026
$7,929.00
500
$15.86
32,797
Doyle Mittie
Chief Medical Officer
Exempt
Apr 01, 2026
$5,459.16
679
$8.04
4,301
Sullivan Christopher Ryan
Chief Financial Officer
Sell
Apr 01, 2026
$125,840.91
7,479
$16.83
25,318
Doyle Mittie
Chief Medical Officer
Sell
Apr 01, 2026
$10,864.00
679
$16.00
3,622
Jain Rita
Award
Mar 31, 2026
$16,242.07
1,339
$12.13
1,339
Lind Kevin Robert
Award
Mar 31, 2026
$16,618.10
1,370
$12.13
1,370
KAPLAN GILLA
Exempt
Mar 28, 2026
$0.00
3,166
$0.00
3,167
Sullivan Christopher Ryan
Chief Financial Officer
Exempt
Mar 28, 2026
$0.00
24,200
$0.00
24,200
NEIL GARRY ARTHUR
Chief Executive Officer
Exempt
Mar 28, 2026
$0.00
64,866
$0.00
64,867
Chan Mitchell
Exempt
Mar 28, 2026
$0.00
3,166
$0.00
3,167
KAPLAN GILLA
Exempt
Mar 28, 2026
$0.00
3,166
$0.00
6,333
KANTOFF AARON
Exempt
Mar 28, 2026
$0.00
3,166
$0.00
3,167
NEIL GARRY ARTHUR
Chief Executive Officer
Exempt
Mar 28, 2026
$0.00
64,866
$0.00
112,006
Chan Mitchell
Exempt
Mar 28, 2026
$0.00
3,166
$0.00
6,333
NEIL GARRY ARTHUR
Chief Executive Officer
In Kind
Mar 28, 2026
$304,079.88
21,892
$13.89
90,114
Truex Samantha
Exempt
Mar 28, 2026
$0.00
3,166
$0.00
3,167
KANTOFF AARON
Exempt
Mar 28, 2026
$0.00
3,166
$0.00
6,333
Sullivan Christopher Ryan
Chief Financial Officer
Exempt
Mar 28, 2026
$0.00
24,200
$0.00
41,538
Truex Samantha
Exempt
Mar 28, 2026
$0.00
3,166
$0.00
6,333
Sullivan Christopher Ryan
Chief Financial Officer
In Kind
Mar 28, 2026
$114,467.49
8,241
$13.89
33,297